Skip to main content

Department of Medicine Archives

Max Planck Institute’s Fässler set for next Discovery Lecture

Nov. 3, 2016—Reinhard Fässler, M.D., director of the Department of Molecular Medicine at the Max Planck Institute in Martinsried, Germany, will deliver the next Flexner Discovery Lecture on Nov. 10.

Read more


Trial to test aortic valve technique in lower-risk patients

Oct. 27, 2016—In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States.

Read more


Study finds natural compound extends lifespan of worms

Oct. 20, 2016—A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered.

Read more


Rheumatoid subtypes explored by PheWAS

Oct. 7, 2016—A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.

Read more


Madhur lands NIH New Innovator Award

Oct. 6, 2016—Meena Madhur, M.D., Ph.D., assistant professor of Medicine, has received an NIH New Innovator Award, which is designed to support exceptionally creative, early-career investigators who propose innovative, high-impact projects.

Read more


BMI genotype and breast cancer risk

Sep. 29, 2016—For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults.

Read more


‘Shed-Meds’ to explore helping elderly reduce number of medications

Sep. 22, 2016—Vanderbilt University Medical (VUMC) researchers have received a $2.9 million federal grant to test the effectiveness of a new intervention that aims to help older patients reduce the number of medications they may be taking on a regular basis.

Read more


H. pylori and anemia – new evidence

Sep. 22, 2016—The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.

Read more


Study explores anti-viral potential of existing drugs

Sep. 15, 2016—Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.

Read more


Going after the ‘heart attack gremlin’

Sep. 8, 2016—A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.

Read more


VUMC mourns loss of Nephrology’s Schulman

Aug. 30, 2016—Gerald Schulman, M.D., professor of Medicine, died Aug. 26. He was 65.

Read more


Nervous system’s role in hypertension

Aug. 29, 2016—Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more